Phase III Clinical Study to Evaluate the Efficacy and Safety of the Combination of Lercanidipine/Valsartan in Hypertensive Patients

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 449 participants.

Also called NCT01928628

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 449 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01928628
Other papers using this trial's data
  • Evaluation of the Efficacy and Safety of the Lercanidipine/Valsartan Combination in Korean Patients With Essential Hypertension Not Adequately Controlled With Lercanidipine Monotherapy: A Randomized, Multicenter, Parallel Design, Phase III Clinical Trial Clinical therapeutics, 2015-08 DOI, PubMed 26164786

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
Not reported
Countries
South Korea (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01928628. Randomized; double masking; primary purpose treatment. Start 2012-05 (registry gives no type); primary completion 2013-04 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Phase III Clinical Study to Evaluate the Efficacy and Safety of the Combination of Lercanidipine/Valsartan in Hypertensive Patients
Condition
Hypertension
Intervention (Drug)
Lercanidipine 10mg
Intervention (Drug)
Lercanidipine10mg /Valsartan 80mg
Intervention (Drug)
Lercanidipine 10mg /Valsartan 160mg
Intervention (Drug)
Lercanidipin 10mg Placebo
Intervention (Drug)
Lercanidipine10mg /Valsartan 80mg Placebo
Intervention (Drug)
Lercanidipine 10mg /Valsartan 160mg Placebo
Lead sponsor
LG Life Sciences (class: industry)

Record details

Record id
cardio:ct-nct01928628
Content hash
ea5167166f9db68a157fa4db4ca838530c93218ff330b0ca33725dcfe88fee4e